Nasdaq · CIK 0001401667
PBYI PUMA BIOTECHNOLOGY, INC.
Insider trading from SEC Form 4. Last filing 26 d ago. Close $10.29 on Oct 9, 2026, +118% from the 52-week low and 0% from the high.
Last 90 days
Net insider value
-$612k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$612k by 2 insiders
Insiders on file
10
with a Form 4 at this company
Price and insider trades, last year
PBYIOct 9, 2026 · close 10.29
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PUMA BIOTECHNOLOGY, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Alessandra Cesano director sell | $567k 62,150 shares | -52% | - | |
| 9Weak | Troy Edward Wilson director sell | $46k 5,000 shares | -8% | - | |
| 25Weak | Alan H Auerbach President and CEO sell | $205k 34,950 shares | -0% | +114% from low-5% from high | |
| 10Weak | Douglas M Hunt See Remarks sell | $53k 8,987 shares | -5% | +114% from low-5% from high | |
| 35Weak | Michael Patrick Miller director sell | $97k 20,000 shares | -27% | +114% from low-13% from high | |
| 29Weak | Alessandra Cesano director sell | $91k 27,000 shares | -39% | +41% from low-9% from high | |
| 31Weak | Alan H Auerbach President and CEO sell | $167k 47,172 shares | -1% | +48% from low-4% from high | |
| 15Weak | Douglas M Hunt See Remarks sell | $28k 7,817 shares | -5% | +48% from low-4% from high | |
| 23Weak | Maximo F Nougues Chief Financial Officer sell | $34k 9,522 shares | -4% | +48% from low-4% from high | |
| 21Weak | Alessandra Cesano director sell | $41k 12,150 shares | -15% | +38% from low-10% from high | |
| 21Weak | Allison Dorval director sell | $39k 11,610 shares | -13% | +38% from low-10% from high | |
| 28Weak | Jay M Moyes director sell | $75k 22,000 shares | -29% | +38% from low-10% from high | |
| 39Weak | Adrian Senderowicz director sell | $92k 27,000 shares | -50% | +38% from low-10% from high | |
| 15Weak | Brian M Stuglik director sell | $27k 8,100 shares | -8% | +38% from low-10% from high | |
| 21Weak | Troy Edward Wilson director sell | $37k 10,800 shares | -20% | +38% from low-10% from high | |
| 23Weak | Alan H Auerbach President and CEO sell | $107k 33,841 shares | -0% | - | |
| 8Weak | Douglas M Hunt See Remarks sell | $27k 8,633 shares | -6% | - |
Transactions
The last 39 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Troy Edward Wilson director | SOpen-market sale Common Stock10b5-1 | -5,000 | $9.10 | $46k | 54,750 | 26 d ago |
| Sep 14, 2026 | Alessandra Cesano director | MOption exercise Common Stock10b5-1 | +50,000 | $2.93 | $147k | 118,850 | 26 d ago |
| Sep 14, 2026 | Alessandra Cesano director | SOpen-market sale Common Stock10b5-1 | -62,150 | $9.12 | $567k | 56,700 | 26 d ago |
| Sep 14, 2026 | Alessandra Cesano director | MOption exercise Stock Optionderivative10b5-1 | -50,000 | $0.00 | $0 | 50,000 | 26 d ago |
| Feb 18, 2026 | Alan H Auerbach President and CEO | AGrant or award Common Stock | +159,778 | $0.00 | $0 | 7,305,729 | Feb 20, 2026 |
| Feb 18, 2026 | Douglas M Hunt See Remarks | AGrant or award Common Stock | +49,394 | $0.00 | $0 | 205,301 | Feb 20, 2026 |
| Feb 18, 2026 | Alan H Auerbach President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +227,474 | $0.00 | $0 | 227,474 | Feb 20, 2026 |
| Feb 18, 2026 | Douglas M Hunt See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +70,321 | $0.00 | $0 | 70,321 | Feb 20, 2026 |
| Jan 6, 2026 | Douglas M Hunt See Remarks | SOpen-market sale Common Stock10b5-1 | -3,973 | $5.84 | $23k | 160,921 | Jan 8, 2026 |
| Jan 6, 2026 | Alan H Auerbach President and CEO | SOpen-market sale Common Stock10b5-1 | -16,938 | $5.84 | $99k | 7,163,963 | Jan 8, 2026 |
| Jan 7, 2026 | Alan H Auerbach President and CEO | SOpen-market sale Common Stock10b5-1 | -18,012 | $5.88 | $106k | 7,145,951 | Jan 8, 2026 |
| Jan 7, 2026 | Douglas M Hunt See Remarks | SOpen-market sale Common Stock10b5-1 | -5,014 | $5.88 | $29k | 155,907 | Jan 8, 2026 |
| Nov 11, 2025 | Michael Patrick Miller director | SOpen-market sale Common Stock | -20,000 | $4.86 | $97k | 54,000 | Nov 13, 2025 |
| Jul 18, 2025 | Alessandra Cesano director | SOpen-market sale Common Stock10b5-1 | -27,000 | $3.37 | $91k | 41,850 | Jul 22, 2025 |
| Jul 8, 2025 | Maximo F Nougues Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -5,587 | $3.53 | $20k | 208,164 | Jul 10, 2025 |
| Jul 8, 2025 | Douglas M Hunt See Remarks | SOpen-market sale Common Stock10b5-1 | -4,374 | $3.53 | $15k | 168,337 | Jul 10, 2025 |
| Jul 8, 2025 | Alan H Auerbach President and CEO | SOpen-market sale Common Stock10b5-1 | -25,592 | $3.53 | $90k | 7,202,481 | Jul 10, 2025 |
| Jul 9, 2025 | Douglas M Hunt See Remarks | SOpen-market sale Common Stock10b5-1 | -3,443 | $3.54 | $12k | 164,894 | Jul 10, 2025 |
| Jul 9, 2025 | Alan H Auerbach President and CEO | SOpen-market sale Common Stock10b5-1 | -21,580 | $3.54 | $76k | 7,180,901 | Jul 10, 2025 |
| Jul 9, 2025 | Maximo F Nougues Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -3,935 | $3.54 | $14k | 204,229 | Jul 10, 2025 |
| Jun 13, 2025 | Alessandra Cesano director | SOpen-market sale Common Stock10b5-1 | -12,150 | $3.40 | $41k | 68,850 | Jun 17, 2025 |
| Jun 13, 2025 | Allison Dorval director | SOpen-market sale Common Stock10b5-1 | -11,610 | $3.40 | $39k | 75,390 | Jun 17, 2025 |
| Jun 13, 2025 | Jay M Moyes director | SOpen-market sale Common Stock10b5-1 | -22,000 | $3.40 | $75k | 53,322 | Jun 17, 2025 |
| Jun 13, 2025 | Adrian Senderowicz director | SOpen-market sale Common Stock10b5-1 | -27,000 | $3.40 | $92k | 27,000 | Jun 17, 2025 |
| Jun 13, 2025 | Brian M Stuglik director | SOpen-market sale Common Stock10b5-1 | -8,100 | $3.39 | $27k | 94,958 | Jun 17, 2025 |
| Jun 13, 2025 | Troy Edward Wilson director | SOpen-market sale Common Stock10b5-1 | -10,800 | $3.40 | $37k | 43,550 | Jun 17, 2025 |
| Jun 11, 2025 | Michael Patrick Miller director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 74,000 | Jun 13, 2025 |
| Jun 11, 2025 | Adrian Senderowicz director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 54,000 | Jun 13, 2025 |
| Jun 11, 2025 | Brian M Stuglik director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 103,058 | Jun 13, 2025 |
| Jun 11, 2025 | Troy Edward Wilson director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 54,350 | Jun 13, 2025 |
| Jun 11, 2025 | Jay M Moyes director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 75,322 | Jun 13, 2025 |
| Jun 11, 2025 | Allison Dorval director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 87,000 | Jun 13, 2025 |
| Jun 11, 2025 | Alessandra Cesano director | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 81,000 | Jun 13, 2025 |
| Feb 7, 2025 | Alan H Auerbach President and CEO | AGrant or award Common Stock | +198,399 | $0.00 | $0 | 7,228,073 | Feb 11, 2025 |
| Feb 7, 2025 | Douglas M Hunt See Remarks | AGrant or award Common Stock | +48,117 | $0.00 | $0 | 172,711 | Feb 11, 2025 |
| Feb 7, 2025 | Alan H Auerbach President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +274,622 | $0.00 | $0 | 274,622 | Feb 11, 2025 |
| Feb 7, 2025 | Douglas M Hunt See Remarks | AGrant or award Stock Option (Right to Buy)derivative | +66,604 | $0.00 | $0 | 66,604 | Feb 11, 2025 |
| Jan 2, 2025 | Alan H Auerbach President and CEO | SOpen-market sale Common Stock10b5-1 | -33,841 | $3.15 | $107k | 7,029,674 | Jan 3, 2025 |
| Jan 2, 2025 | Douglas M Hunt See Remarks | SOpen-market sale Common Stock10b5-1 | -8,633 | $3.15 | $27k | 124,594 | Jan 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Alan H AuerbachPresident and CEO
- Alessandra Cesanodirector
- Allison Dorvalcfo, officer, director
- Douglas M HuntSee Remarks
- Michael Patrick Millerdirector
- Jay M Moyesdirector
- Maximo F NouguesChief Financial Officer
- Adrian Senderowiczdirector
- Brian M Stuglikdirector
- Troy Edward Wilsonceo, president, officer, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.